|
Security
Type
|
Security Class
Title
|
Fee
Calculation
Rule
|
Amount
Registered (1)
|
Proposed
Maximum
Offering
Price Per
Unit
|
Maximum
Aggregate
Offering Price
|
Fee Rate
|
Amount of
Registration
Fee
|
|||||||||||||||||
|
Fees to Be Paid
|
Equity
|
Common Stock, par value $0.0001 per share
|
457(c)
|
52,892,500
|
(2)
|
$
|
3.28
|
(3)
|
$
|
$173,487,400
|
0.00015310
|
$
|
$26,560.93
|
|||||||||||
|
Total Offering Amounts
|
$
|
173,487,400
|
$
|
26,560.93
|
||||||||||||||||||||
|
Total Fee Offsets
|
$
|
—
|
$
|
—
|
||||||||||||||||||||
|
Net Fee Due
|
$
|
173,487,400
|
$
|
26,560.93
|
||||||||||||||||||||
|
(1)
|
Represents the shares of common stock, $0.0001 par value per share (the “Common Stock”), of Senti Biosciences, Inc. (the “Registrant”) that will be offered for resale by the selling stockholders pursuant to
the registration statement to which this exhibit is attached. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares being registered hereunder include such indeterminate number of additional
shares of common stock as may be issuable as a result of stock splits, stock dividends or similar transactions with respect to the shares being registered hereunder.
|
|
(2)
|
Consists of (i) 21,157,000 shares of Common Stock, issuable upon conversion of 21,157 shares of Series A Convertible Preferred Stock, par value $0.0001 per share, and (ii) 31,735,500 shares of Common Stock
issuable upon conversion of warrants to purchase shares of Common Stock.
|
|
(3)
|
This estimate is made pursuant to Rule 457(c) of the Securities Act solely for purposes of calculating the registration fee. The price per share and aggregate offering price are based upon the average of the
high and low prices of the Registrant’s Common Stock on March 13, 2025, as reported on the Nasdaq Capital Market.
|